Castlekeep Investment Advisors LLC Buys Shares of 10,632 Cardinal Health, Inc. (NYSE:CAH)

Castlekeep Investment Advisors LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,632 shares of the company's stock, valued at approximately $1,257,000.

A number of other large investors also recently bought and sold shares of CAH. Cyrus J. Lawrence LLC acquired a new stake in shares of Cardinal Health during the 4th quarter worth $26,000. Promus Capital LLC purchased a new stake in Cardinal Health during the fourth quarter valued at about $30,000. Bellwether Advisors LLC acquired a new stake in Cardinal Health during the fourth quarter worth about $32,000. Lee Danner & Bass Inc. purchased a new position in shares of Cardinal Health in the 4th quarter worth about $35,000. Finally, Itau Unibanco Holding S.A. acquired a new position in shares of Cardinal Health in the 4th quarter valued at about $36,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Performance

Shares of Cardinal Health stock traded up $1.90 during trading on Tuesday, reaching $154.65. The company had a trading volume of 1,901,089 shares, compared to its average volume of 2,230,522. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $156.44. The firm's fifty day moving average is $139.99 and its 200-day moving average is $129.49. The company has a market cap of $36.91 billion, a price-to-earnings ratio of 28.85, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The firm had revenue of $54.88 billion during the quarter, compared to analyst estimates of $55.33 billion. During the same period in the previous year, the company earned $2.08 earnings per share. Cardinal Health's quarterly revenue was up .0% on a year-over-year basis. On average, research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a dividend of $0.5107 per share. The ex-dividend date is Tuesday, July 1st. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a yield of 1.32%. Cardinal Health's dividend payout ratio (DPR) is 31.83%.

Analyst Ratings Changes

A number of analysts recently issued reports on CAH shares. UBS Group increased their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a research report on Tuesday, April 29th. Wells Fargo & Company increased their price objective on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 4th. Jefferies Financial Group upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and lifted their target price for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. Morgan Stanley upped their price target on shares of Cardinal Health from $142.00 to $166.00 and gave the stock an "overweight" rating in a research report on Monday, May 5th. Finally, Argus set a $148.00 target price on shares of Cardinal Health in a research note on Tuesday, February 4th. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $146.43.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.